The Kampo medicine, Goshajinkigan, prevents neuropathy in patients treated by FOLFOX regimen

International Journal of Clinical Oncology

Volumn 16, Issue 4, 2011, Pages 322-327

  Nishioka, Masanori ^a   Shimada, Mitsuo ^a   Kurita, Nobuhiro ^a   Iwata, Takashi ^a   Morimoto, Shinya ^a   Yoshikawa, Kozo ^a   Higashijima, Jun ^a   Miyatani, Tomohiko ^a   Kono, Toru ^b  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

Colorectal cancer; Goshajinkigan; Kampo medicine; Neuropathy; Oxaliplatin

Indexed keywords

BEVACIZUMAB; FLUOROURACIL; FOLINIC ACID; GOSHAJINKIGAN; KAMPO; OXALIPLATIN; UNCLASSIFIED DRUG;

ADULT; AGED; ANOREXIA; ARTICLE; CANCER PATIENT; CLINICAL ARTICLE; COLORECTAL CANCER; CONTINUOUS INFUSION; CONTROLLED STUDY; DIARRHEA; DRUG DOSE REDUCTION; DRUG EFFICACY; FEMALE; HUMAN; INCIDENCE; MALE; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUROPATHY; NEUTROPENIA; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; VOMITING;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COLORECTAL NEOPLASMS; DRUGS, CHINESE HERBAL; FEMALE; FLUOROURACIL; HUMANS; LEUCOVORIN; MALE; MEDICINE, KAMPO; MIDDLE AGED; ORGANOPLATINUM COMPOUNDS; PERIPHERAL NERVOUS SYSTEM DISEASES;

EID: 80052738134     PISSN: 13419625     EISSN: 14377772     Source Type: Journal    
DOI: 10.1007/s10147-010-0183-1     Document Type: Article

References (31)

1. A de Gramont A Figer M Seymour, et al. 2000 Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer J Clin Oncol 18 2938 2947 10944126 (Pubitemid 30644117)
2. T Andre C Boni L Mounedji-Boudiaf, et al. 2004 Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer N Engl J Med 350 2343 2351 10.1056/NEJMoa032709 (Pubitemid 38702845)
3. J Cassidy J-L Misset 2002 Oxaliplatin-related side effects: characteristics and management Semin Oncol 29 11 20 12422304 10.1053/sonc.2002.35524 1:CAS:528:DC%2BD38XoslWitb4%3D (Pubitemid 35191037)
4. AV Krishnan D Goldstein M Friedlander, et al. 2005 Oxaliplatin-induced neurotoxicity and the development of neuropathy Muscle Nerve 32 51 60 15880395 10.1002/mus.20340 1:CAS:528:DC%2BD2MXmsV2lsb8%3D (Pubitemid 40917889)
5. SR Land JA Kopec RS Cecchini, et al. 2007 Neurotoxicity from oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: NSABP C-07 J Clin Oncol 25 2205 2211 17470850 10.1200/JCO.2006.08.6652 1:CAS:528:DC%2BD2sXnsVShtLk%3D (Pubitemid 46954644)
6. C Tournigand A Cervantes A Figer, et al. 2006 OPTIMOX1: a randomized study of FOLFOX4 or FOLFOX7 with oxaliplatin in a stop-and-go fashion in advanced colorectal cancer: GERCOR study J Clin Oncol 24 394 400 16421419 10.1200/JCO.2005.03.0106 1:CAS:528:DC%2BD28XhsFSku7w%3D (Pubitemid 46630458)
7. L Gamelin M Boisdron-Celle R Delva, et al. 2004 Prevention of oxaliplatin-related neurotoxicity by calcium and magnesium infusions: a retrospective study of 161 patients receiving oxaliplatin combined with 5-fluorouracil and leucovorin for advanced colorectal cancer Clin Cancer Res 10 4055 4061 15217938 10.1158/1078-0432.CCR-03-0666 1:CAS:528:DC%2BD2cXltFWmur4%3D (Pubitemid 38812481)
8. E Gamelin L Gamelin L Bossi, et al. 2002 Clinical aspects and molecular basis of oxaliplatin neurotoxicity: current management and development of preventive measures Semin Oncol 29 21 33 12422305 10.1053/sonc.2002.35525 1:CAS:528:DC%2BD38XoslWitbw%3D (Pubitemid 35191038)
9. S Cascinu V Catalano L Cordella, et al. 2002 Neuroprotective effect of reduced glutathione on oxaliplatin-based chemotherapy in advanced colorectal cancer: a randomized, double-blind, placebo-controlled trial J Clin Oncol 20 3478 3483 12177109 10.1200/JCO.2002.07.061 1:CAS:528:DC%2BD38XntVyjtr4%3D
10. PC Lin MY Lee WS Wang, et al. 2006 N-acetylcysteine has neuroprotective effects against oxaliplatin-based adjuvant chemotherapy in colon cancer patients: preliminary data Support Care Cancer 14 484 487 16450089 10.1007/s00520-006-0018-9
11. E Susman 2006 Xaliproden lessens oxaliplatin-mediated neuropathy Lancet Oncol 7 4 288 16598880 10.1016/S1470-2045(06)70639-8
12. S von Delius F Eckel S Wagenpfeil, et al. 2007 Carbamazepine for prevention of oxaliplatinrelated neurotoxicity in patients with advanced colorectal cancer: final results of a randomised, controlled, multicenter phase II study Invest New Drugs 25 173 180 10.1007/s10637-006-9010-y (Pubitemid 46020877)
13. WS Wang JK Lin TC Lin, et al. 2007 Oral glutamine is effective for preventing oxaliplatin-induced neuropathy in colorectal cancer patients Oncologist 12 3 312 319 17405895 10.1634/theoncologist.12-3-312 1:CAS:528:DC%2BD2sXlsVSqtbg%3D (Pubitemid 46556797)
14. Y Nagaki S Hayasaka Y Hayasaka, et al. 2003 Effects of goshajinkigan on corneal sensitivity, superficial punctate keratopathy and tear secretion in patients with insulin-dependent diabetes mellitus Am J Chin Med 31 103 109 12723759 10.1142/S0192415X03000771 (Pubitemid 41758864)
15. X Yao H Chen S Emura, et al. 2007 Effects of hPTH (1-34) and Gosha-jinki-gan on the trabecular bone microarchitecture in ovariectomized rat tibia Okajimas Folia Anat Jpn 83 107 113 17380852 10.2535/ofaj.83.107 1:CAS:528:DC%2BD2sXktVeitb8%3D
16. T Yamamoto T Murai M Ueda, et al. 2009 Clinical features of paclitaxel-induced peripheral neuropathy and role of Gosya-jinki-gan Gan To Kagaku Ryoho 36 1 89 92 19151569
17. T Uno I Ohsawa M Tokudome, et al. 2005 Effects of Goshajinkigan on insulin resistance in patients with type 2 diabetes Diabetes Res Clin Pract 69 129 135 16005362 10.1016/j.diabres.2004.11.017 (Pubitemid 40943477)
18. Kono T, Mamiya N, Chisato N et al (2009) Efficacy of Goshajinkigan for peripheral neurotoxicity of oxaliplatin in patients with advanced or recurrent colorectal cancer. Evid Based Complement Alternat Med. 1. (eCAM. doi: 10.1093/ecam/nep200 )
19. K Shirao Y Matsumura Y Yamada, et al. 2006 Phase I study of single-dose oxaliplatin in Japanese patients with malignant tumors Jpn J Clin Oncol 36 295 300 16702162 10.1093/jjco/hyl016 (Pubitemid 43997334)
20. P Therasse SG Arbuck EA Eisenhauer, et al. 2000 New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada J Natl Cancer Inst 92 205 216 10655437 10.1093/jnci/92.3.205 1:STN:280:DC%2BD3c7it1Gitg%3D%3D
21. K Ishibashi N Okada T Miyazaki, et al. 2010 Effect of calcium and magnesium on neurotoxicity and blood platinum concentrations in patients receiving mFOLFOX6 therapy: a prospective randomized study Int J Clin Oncol 15 1 82 87 20108160 10.1007/s10147-009-0015-3 1:CAS:528:DC%2BC3cXhslOnt7k%3D
22. BJ Gwag FM Sessler V Robine, et al. 1997 Endogenous glutamate levels regulate nerve growth factor mRNA expression in the rat dentate gyrus Mol Cells 7 425 430 9264033 1:CAS:528:DyaK2sXksF2gu7Y%3D (Pubitemid 127486228)
23. Daikhin Y, Yudkoff M (2000) Compartmentation of brain glutamate metabolism in neurons and glia. J Nutr 130(4S Suppl):1026S-1031S (Pubitemid 30173638)
24. C Meijer EG de Vries P Marmiroli, et al. 1999 Cisplatin-induced DNA-platination in experimental dorsal root ganglia neuronopathy Neurotoxicology 20 883 887 10693969 1:CAS:528:DC%2BD3cXhtFyjsLo%3D (Pubitemid 30091215)
25. T Kono H Mishima M Shimada, et al. 2009 GONE Investigators. Preventive effect of goshajinkigan on peripheral neurotoxicity of FOLFOX therapy: a placebo-controlled double-blind randomized phase II study (the GONE Study) Jpn J Clin Oncol 39 12 847 849 19734172 10.1093/jjco/hyp100
26. HS Hochster A Grothey BH Childs 2007 Use of calcium and magnesium salts to reduce oxaliplatin-related neurotoxicity J Clin Oncol 25 4028 4029 17664456 10.1200/JCO.2007.13.5251 (Pubitemid 47477294)
27. K Yamada E Suzuki T Nakaki, et al. 2005 Aconiti tuber increases plasma nitrite and nitrate levels in humans J Ethnopharmacol 96 165 169 15588666 10.1016/j.jep.2004.09.028 (Pubitemid 39575047)
28. A Gotoh K Goto A Sengoku, et al. 2004 Inhibition mechanism of Gosha-jinki-gan on the micturition reflex in rats J Pharmacol Sci 96 115 123 15502402 10.1254/jphs.FPJ03098X 1:CAS:528:DC%2BD2cXptVKgtrk%3D (Pubitemid 39469602)
29. X Hu J Sato Y Oshida, et al. 2003 Effect of Gosha-jinki-gan (Chinese herbal medicine: Niu-Che-Sen-Qi-Wan) on insulin resistance in streptozotocin-induced diabetic rats Diabetes Res Clin Pract 59 103 111 12560159 10.1016/S0168-8227(02)00203-6 (Pubitemid 36135828)
30. Joseph EK, Chen X, Bogen O et al (2008) Oxaliplatin acts on IB4-positive nociceptors to induce an oxidative stress-dependent acute painful peripheral neuropathy. J Pain 9(5):463-472
31. T Imamura O Ishizuka N Aizawa, et al. 2008 Gosha-jinki-gan reduces transmitter proteins and sensory receptors associated with C fiber activation induced by acetic acid in rat urinary bladder Neurourol Urodyn 27 8 832 837 18551569 10.1002/nau.20559 1:CAS:528:DC%2BD1cXhsFWrur7I